|
Index of reports
> All cases (25)
> Cases with Confusional State (6)
Below is the selection of adverse event reports related to MS Contin (Morphine) that includes all cases where reactions include confusional state.
Adverse event in male receiving MS Contin (Morphine)
Reported by a individual with unspecified qualification on 2007-10-12
Patient: male
Adverse reactions / side effects: Confusional State, Paranoia, Hallucination, Delusion, Aggression
Suspect drug(s):
Desyrel
Dosage: 75 mg, daily
Indication: Drug USE FOR Unknown Indication
Morphine Sulfate
Dosage: 5 mg, prn
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
MS Contin
Dosage: unk, unk
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Adverse event in 42 year old female receiving MS Contin (Morphine)
Reported by a physician from United States on 2007-06-27
Patient: 42 year old female
Adverse reactions / side effects: Confusional State, Dyspnoea, Neuropathy Peripheral, Abnormal Behaviour, Drug Interaction, Mood Swings, Disease Progression
Suspect drug(s):
MS Contin
Dosage: 15 mg qd po
Administration route: Oral
Indication: Complex Regional Pain Syndrome
Start date: 2006-10-01
Namenda
Dosage: 10 mg bid po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-01-01
End date: 2006-12-13
Namenda
Dosage: 5 mg bid po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-12-14
End date: 2006-12-20
Namenda
Dosage: 5 mg qd po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-11-01
End date: 2006-01-01
Namenda
Dosage: 5 mg bid po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-01-01
End date: 2006-01-01
Namenda
Dosage: 15 mg qd po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-01-01
End date: 2006-01-01
Other drugs received by patient: Warfarin Sodium; Crestor; Darvocet; Spiriva; Levoxyl; Oxygen
Adverse event in 42 year old female receiving MS Contin (Morphine)
Reported by a physician from United States on 2007-05-09
Patient: 42 year old female
Adverse reactions / side effects: Back Pain, Confusional State, Dyspnoea, Abnormal Behaviour, Condition Aggravated, Drug Interaction, Cognitive Disorder, Amnesia, Complex Regional Pain Syndrome, Neuropathy Peripheral, Mood Swings
Suspect drug(s):
MS Contin
Dosage: 15 mg qd po
Administration route: Oral
Indication: Complex Regional Pain Syndrome
Start date: 2006-10-01
Namenda
Dosage: 10 mg bid po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-01-01
End date: 2006-12-13
Namenda
Dosage: 5 mg bid po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-12-14
End date: 2006-12-20
Namenda
Dosage: 5 mg qd po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-11-01
End date: 2006-01-01
Namenda
Dosage: 5 mg bid po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-01-01
End date: 2006-01-01
Namenda
Dosage: 15 mg qd po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-01-01
End date: 2006-01-01
Other drugs received by patient: Warfarin Sodium; Crestor; Darvocet; Spiriva; Levoxyl; Oxygen
Adverse event in 56 year old male receiving MS Contin (Morphine)
Reported by a individual with unspecified qualification on 2007-04-16
Patient: 56 year old male
Adverse reactions / side effects: Confusional State, Nausea, Therapeutic Agent Toxicity, Somnolence, Anticonvulsant Drug Level Increased, Dizziness, Gait Disturbance, Neutropenia, Thrombocytopenia
Adverse event resulted in: disablity
Suspect drug(s):
Dilantin
Dosage: 300 mg, unk
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
MS Contin
Dosage: 20 mg, unk
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Sutent
Dosage: 50 mg, unk
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Adverse event in 56 year old male receiving MS Contin (Morphine)
Reported by a individual with unspecified qualification on 2007-04-12
Patient: 56 year old male
Adverse reactions / side effects: Confusional State, Nausea, Therapeutic Agent Toxicity, Somnolence, Anticonvulsant Drug Level Increased, Dizziness, Gait Disturbance, Neutropenia, Thrombocytopenia
Adverse event resulted in: disablity
Suspect drug(s):
Dilantin
Dosage: 300 mg, unk
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
MS Contin
Dosage: 20 mg, unk
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Sutent
Dosage: 50 mg, unk
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Adverse event in 42 year old female receiving MS Contin (Morphine)
Reported by a physician from United States on 2007-03-13
Patient: 42 year old female
Adverse reactions / side effects: Back Pain, Confusional State, Dyspnoea, Abnormal Behaviour, Drug Interaction, Amnesia, Disease Progression, Hyperaesthesia, Neuropathy Peripheral, Mood Swings
Suspect drug(s):
MS Contin
Dosage: 15 mg qd po
Administration route: Oral
Indication: Complex Regional Pain Syndrome
Start date: 2006-10-01
Namenda
Dosage: 10 mg bid po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-01-01
End date: 2006-12-13
Namenda
Dosage: 5 mg bid po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-12-14
End date: 2006-12-20
Namenda
Dosage: 5 mg qd po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-11-01
End date: 2006-01-01
Namenda
Dosage: 5 mg bid po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-01-01
End date: 2006-01-01
Namenda
Dosage: 15 mg qd po
Administration route: Oral
Indication: Neuropathy Peripheral
Start date: 2006-01-01
End date: 2006-01-01
Other drugs received by patient: Warfarin Sodium; Crestor; Darvocet (Propoxyphene / Acetaminophen); Spiriva; Levoxyl; Oxygen
|
